Cargando…

Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.

The expression of pS2 was examined histochemically in paraffin sections taken from biopsy material from patients diagnosed with ductal carcinoma in situ (DCIS). Often intense immunoreactivity, to an anti-pS2 monoclonal antibody, was observed in comedo, solid, cribriform and micropapillary types of D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luqmani, Y. A., Campbell, T., Soomro, S., Shousha, S., Rio, M. C., Coombes, R. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968340/ https://www.ncbi.nlm.nih.gov/pubmed/8385977

Ejemplares similares

Expression of Cancer/Testis genes in ductal carcinoma in situ and benign lesions of the breast
por: Caballero, Otavia L., et al.
Publicado: (2013)

Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)

Glutathione localisation in benign and malignant human breast lesions.
por: Murray, G. I., et al.
Publicado: (1987)

Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast
por: Perez, Amanda Arantes, et al.
Publicado: (2013)

Isolation of a lactoferrin cDNA clone and its expression in human breast cancer.
por: Campbell, T., et al.
Publicado: (1992)

Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients.
por: Schoenfeld, A., et al.
Publicado: (1996)

Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast.
por: al-Tubuly, A. A., et al.
Publicado: (1996)

Immunohistochemical expression of interleukin-17 and hormonal receptors in benign and malignant breast lesions
por: Ali, Eman Taha, et al.
Publicado: (2020)

Ductal carcinoma in situ in a benign phyllodes tumor of breast: A rare presentation
por: Ghosh, Prithwijit, et al.
Publicado: (2014)

Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast
por: Regele, S, et al.
Publicado: (1999)

Preoperative Localisation of Impalpable Breast Lesions
por: Reidy, J. F.
Publicado: (1989)

Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance.
por: Yiangou, C., et al.
Publicado: (1997)

Loss of Mammographic Tissue Homeostasis in Invasive Lobular and Ductal Breast Carcinomas vs. Benign Lesions
por: Gerasimova-Chechkina, Evgeniya, et al.
Publicado: (2021)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Pleomorphic Invasive Ductal Carcinoma of the Breast in a Patient with Huntington's Disease
por: Shousha, Sami
Publicado: (2014)

All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4
por: Shousha, Sami, et al.
Publicado: (2019)

Study of the Immunohistochemical Expression of p63 in Benign Lesions and Carcinoma of the Breast at a Tertiary Hospital in South India
por: Prabhu, Shreya Dinesh, et al.
Publicado: (2023)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Complete Removal of the Lesion as a Guidance in the Management of Patients with Breast Ductal Carcinoma In Situ
por: Nicosia, Luca, et al.
Publicado: (2021)

Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status
por: Li, Xiaojun, et al.
Publicado: (2023)

Breast lesion localisation wires: a change in practice
por: Pavis, AJ, et al.
Publicado: (2006)

Haematoma-directed ultrasound guidewire localisation of breast lesions
por: Lee, CM, et al.
Publicado: (2009)

Genetic predisposition to ductal carcinoma in situ of the breast
por: Petridis, Christos, et al.
Publicado: (2016)

Malignant Adenomyoepithelioma of the Breast with Lymph Node Metastasis: A Detailed Immunohistochemical Study
por: Awamleh, Ahlam A., et al.
Publicado: (2012)

SONOELASTOGRAPHIC FEATURES OF HIGH-RISK BREAST LESIONS AND DUCTAL CARCINOMA IN SITU – A PILOT STUDY
por: Crnogorac, Maja, et al.
Publicado: (2019)

Role of HGF in epithelial–stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ
por: Casbas-Hernandez, Patricia, et al.
Publicado: (2013)

DNA methylation in ductal carcinoma in situ of the breast
por: Pang, Jia-Min B, et al.
Publicado: (2013)

Immunohistochemical localisation of tissue plasminogen activator in human brain tumours.
por: Franks, A. J., et al.
Publicado: (1989)

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast
por: Robanus-Maandag, E, et al.
Publicado: (2000)

Study of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast Cancer
por: Dobrescu, Andrei, et al.
Publicado: (2011)

Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast
por: Pang, Jia-Min B., et al.
Publicado: (2015)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis
por: Zhang, Geng, et al.
Publicado: (2020)

Breast Ductal Carcinoma in Situ: Morphologic and Kinetic MRI Findings
por: Nadrljanski, Mirjan M., et al.
Publicado: (2013)

Rolling out radioguided occult lesion localisation for breast tumours
por: Chung, David K V
Publicado: (2015)

Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy
por: Clark, Andrea J., et al.
Publicado: (2016)

Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast
por: He, Xiaofang, et al.
Publicado: (2017)

Retinoic Acid Receptor and Retinoid × Receptor in Ductal Carcinoma in situ and Intraductal Proliferative Lesions of the Human Breast
por: Ariga, Naohiro, et al.
Publicado: (2000)

Correlation between imaging and pathology in ductal carcinoma in situ of the breast
por: de Roos, Marnix AJ, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_13q2hd97kb8nranorle90iptdr